The investigational bispecific antibody ubamatamab (REGN4018) has shown potential in the treatment of recurrent ovarian cancer, according to a phase I study presented at the International Gynecologic Cancer Society (IGCS) annual meeting. Dr. Roisin O’Cearbhaill from Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College shared updated results of the study, highlighting the safety
Health
Euthyroid Hashimoto’s thyroiditis can greatly impact a patient’s quality of life. However, a recent study conducted by Geir Hoff, MD, PhD, and his colleagues from the University of Oslo in Norway, suggests that total thyroidectomy may offer significant improvements in patient-reported general health for up to 5 years after surgery. In this article, we will